Controlled release drug delivery is a form of dosage system that aids in the delivery the drug over an extended period of time or at a specific duration. It is a system that provides continuous delivery of medication or drug throughout the treatment. Controlled release drug delivery systems use drug encapsulating devices from which medication or drug is released for a long period of time at a controlled rate, ranging from days to months. Controlled release drug delivery system has many benefits, including enhanced drug stability, lower dose requirement, minimal side effects, enhanced drug safety and efficacy, enhanced patient compliance, and increased bioavailability.

Increasing awareness of the benefits of controlled release drug delivery systems over conventional drug delivery systems is driving the growth of the market. Furthermore, a controlled release drug delivery system allows a dose reduction that reduces the risk of overdose in older people. However, complicated manufacturing processes and strict government regulations are likely to hamper the growth of the market for controlled release of drug delivery. Moreover, some of the biopharmaceutical challenges in developing controlled release drug delivery systems such as setting desired release profiles for new chemical entities, dose dumping risk management, and selection of biocompatible and biodegradable materials with desired controlled release properties are also limiting the market growth.

The market of controlled release drug delivery system is segmented on the basis of technology and type. Furthermore, on the basis of technology the market is divided into transdermal, coacervation, microencapsulation, implants, Wurster technique, targeted delivery, and others. On the basis of type, the market is segmented into infusion pumps, injectable, transdermal and ocular patches, metered dose inhalers, and oral controlled-drug delivery systems. The key players of this market are Merck and Co., Inc., Orbis Biosciences, Inc., Pfizer, Inc., AstraZeneca PLC, Bristol-Myers Squibb Co., Mylan N.V. and Janssen Pharmaceuticals, Inc.

Research Methodology:                                                      

The market study of the global controlled release drug delivery market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include:

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report is intended for government and private companies for overall market analysis and competitive analysis. The report provides in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

• Global Controlled Release Drug Delivery Market Research and Analysis by Type
• Global Controlled Release Drug Delivery Market Research and Analysis by Technology

The Report Covers:

• Comprehensive research methodology of the global controlled release drug delivery market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global controlled release drug delivery market.
• Insights about market determinants which are stimulating the global controlled release drug delivery market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.